Telegraph Hill Partners Announces Appointment of Paul D. Grossman as Venture Partner
February 10, 2014
San Francisco, CA-—Telegraph Hill Partners (THP), a leading venture capital and growth equity firm dedicated exclusively to life science and healthcare investing, today announced the addition of Paul D. Grossman, Ph.D. to its investment team as a Venture Partner. Dr. Grossman, a 32-year veteran of the life science industry, has extensive experience within the laboratory [...]
February 10, 2014
Cambridge, UK: Horizon Discovery™ (Horizon), a leading provider of research tools to support translational genomics and the development of personalized medicines, today announced it has launched the first products and services from its new GENASSIST™ range of gene editing kits and reagents that enable easier, robust implementation of CRISPR and rAAV gene editing experiments. The [...]
February 10, 2014
HORIBA announces the acquisition of the global assets of Photon Technology International, Inc. and its affiliate companies (Photon Technology International or PTI). HORIBA Instruments Inc. (based in the U.S.) and other HORIBA Scientific group companies have acquired PTI’s worldwide business assets with the aim of increasing market share in fluorescence spectroscopy by taking advantage of [...]
February 10, 2014
BILLERICA, Mass — RainDance Technologies, Inc., an innovative genomics tools company ‘democratizing’ molecular testing of complex diseases, today announced that it has developed a comprehensive next-generation sequencing (NGS) panel for profiling actionable cancer mutations, enabling researchers to rapidly and cost-effectively analyze precious biopsy specimens. The ThunderBolts™ Cancer Panel targets 49 known cancer genes, including tumor [...]
3D liver model expert Zyoxel Ltd to become CN Bio Innovations Ltd
February 10, 2014
OXFORD, England---Zyoxel, an expert in advanced in vitro 3D liver models for drug discovery and drug testing, has today announced it is changing its name to CN Bio Innovations Ltd (CNBIO). The move is part of a strategic rebrand designed to closer align the organisation with its Hong Kong-based holding company, CN Innovations Holdings Limited [...]
BioNano Genomics to Map Human Genome at AGBT 2014
February 10, 2014
SAN DIEGO and MARCO ISLAND, Fla. -- BioNano Genomics announced today that they will map a human genome de novo during the 15th Annual Advances in Genome Biology and Technology (AGBT) meeting, which will be held February 12 to 15 in Marco Island, Florida. During the four days of the conference, BioNano will use the [...]
February 10, 2014
Westlake, OH. GenomOncology and Vanderbilt-Ingram Cancer Center (VICC) today announced a partnership for the exclusive commercial development of a decision support tool based on My Cancer Genome™, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Through this collaboration, GenomOncology and VICC will enhance My Cancer Genome through the development of [...]
RUBICON GENOMICS LAUNCHES PICOPLEX™ DNA-SEQ FOR ILLUMINA NGS PLATFORMS
February 10, 2014
Ann Arbor, MI -- Rubicon Genomics, Inc. today announced the launch of its PicoPLEX™ DNA-seq Kits for use with Illumina next-generation sequencing (NGS) platforms. PicoPLEX’s outstanding robustness and reproducibility have made it the worldwide standard for single-cell DNA amplification for microarray and PCR-based pre-implantation genetic screening and diagnosis. PicoPLEX DNA-seq now enables researchers and clinicians [...]
Patent technology revolutionizes dried blood spot preparation and analysis
February 10, 2014
Spark Holland B.V. is pleased to announce the publication of US patent no. US 8586382 B2 which relates to a method and an apparatus for desorption of a blood sample from a medical test sheet comprising at least one dried blood spot (DBS) for the purpose of biomedical analysis of the blood sample. The patent [...]
Pacific Biosciences Highlights Increased Focus on Human Genome Research at AGBT 2014
February 10, 2014
MENLO PARK, Calif.-- Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology will be featured in nine podium presentations and 29 posters at this year's Advances in Genome Biology and Technology (AGBT) meeting, with more than half presenting research on [...]
